Agios Pharm Stock Options
| AGIO Stock | USD 34.54 0.81 2.40% |
Agios Pharm's latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.78. The total put volume is at 32.0, with calls trading at the volume of 25.0. This yields a 1.28 put-to-call volume ratio. The Agios Pharm option chain provides detailed quote and price information for the current Agios Pharm option contracts. It shows all of Agios Pharm's listed puts, calls, expiration dates, strike prices, and other pricing information.
Agios Pharm Maximum Pain Price Across 2025-03-21 Option Contracts
Max pain occurs when Agios Pharm's market makers reach a net positive position across all Agios Pharm's options at a strike price where option holders stand to lose the most money. By contrast, Agios Pharm's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Agios Pharm
Analyzing Agios Pharm's in-the-money options over time can help investors to take a profitable long position in Agios Pharm regardless of its overall volatility. This is especially true when Agios Pharm's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Agios Pharm's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Agios Pharm's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Agios Pharm lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Agios Pharm's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Agios Pharm contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Agios Stock moves the wrong way.
Agios Pharm In The Money Call Balance
When Agios Pharm's strike price is surpassing the current stock price, the option contract against Agios Pharm stock is said to be in the money. When it comes to buying Agios Pharm's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Agios Pharm are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Agios Current Options Market Mood
Agios Pharm's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Agios Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most Agios Pharm's options investors are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Agios Pharm's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Agios Pharm's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Agios contract
Base on the Rule 16, the options market is currently suggesting that Agios Pharm will have an average daily up or down price movement of about 0.0488% per day over the life of the 2025-03-21 option contract. With Agios Pharm trading at USD 34.54, that is roughly USD 0.0168. If you think that the market is fully incorporating Agios Pharm's daily price movement you should consider buying Agios Pharm options at the current volatility level of 0.78%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Agios |
Purchasing Agios Pharm options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Agios calls. Remember, the seller must deliver Agios Pharm stock to the call owner when a call is exercised.
Agios Pharm Option Chain
When Agios Pharm's strike price is surpassing the current stock price, the option contract against Agios Pharm stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Agios Pharm's option chain is a display of a range of information that helps investors for ways to trade options on Agios. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Agios. It also shows strike prices and maturity days for a Agios Pharm against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | AGIO250321C00017500 | 1 | 17.5 | 15.2 - 19.5 | 17.89 | In |
Call | AGIO250321C00020000 | 0 | 20.0 | 12.5 - 17.0 | 12.5 | In |
Call | AGIO250321C00022500 | 0 | 22.5 | 10.3 - 15.0 | 10.3 | In |
Call | AGIO250321C00025000 | 0 | 25.0 | 8.6 - 12.5 | 8.6 | In |
Call | AGIO250321C00030000 | 0 | 30.0 | 5.5 - 7.4 | 5.5 | In |
Call | AGIO250321C00035000 | 15 | 35.0 | 2.35 - 3.5 | 3.05 | Out |
Call | AGIO250321C00040000 | 0 | 40.0 | 0.7 - 1.95 | 1.35 | |
Call | AGIO250321C00045000 | 0 | 45.0 | 0.0 - 0.65 | 0.65 | |
Call | AGIO250321C00050000 | 0 | 50.0 | 0.0 - 1.2 | 0.25 | |
Put | AGIO250321P00017500 | 0 | 17.5 | 0.0 - 0.75 | 0.75 | |
Put | AGIO250321P00020000 | 0 | 20.0 | 0.0 - 0.8 | 0.8 | |
Put | AGIO250321P00022500 | 0 | 22.5 | 0.0 - 0.95 | 0.95 | |
Put | AGIO250321P00025000 | 0 | 25.0 | 0.2 - 0.7 | 0.2 | |
Put | AGIO250321P00030000 | 0 | 30.0 | 1.0 - 2.25 | 1.0 | |
Put | AGIO250321P00035000 | 0 | 35.0 | 2.8 - 4.5 | 3.15 | In |
Put | AGIO250321P00040000 | 0 | 40.0 | 5.1 - 7.9 | 5.1 | In |
Put | AGIO250321P00045000 | 0 | 45.0 | 8.9 - 12.8 | 8.9 | In |
Put | AGIO250321P00050000 | 0 | 50.0 | 13.5 - 17.5 | 13.5 | In |
Agios Pharm Market Cap Over Time
Market Cap |
| Timeline |
Agios Total Stockholder Equity
Total Stockholder Equity |
|
Agios Pharm Corporate Management
| DSc FRSC | CoFounder Board | Profile | |
| Dr DACVP | Consultant | Profile | |
| Sarah MD | Chief Development | Profile | |
| James Burns | Corporate Officer | Profile | |
| Clive Patience | Chief Officer | Profile | |
| ShinSan Su | CoFounder Board | Profile | |
| Brian MBA | CEO Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 11.66 | Revenue Per Share | Quarterly Revenue Growth 0.212 | Return On Assets | Return On Equity |
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.